- Welcome to SynInnova
- +1 780 485 2962
- sales@syninnova.com
- Welcome Guest
Lenvatinib mesylate
Our Main Products
Shipping
World wide shipping
24 X 7 service
online service for 24 x 7
Latest Products
Updated Product Catalog
New Products 
SI-1589
Lenvatinib mesylate, >98%
CAS No. : [857890-39-2]
MDL No. : MFCD18633219
IUPAC Name : 4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate
| Price And Availability | ||||
|---|---|---|---|---|
| Pack Size | Price in USD | Add To Shopping Cart | Availability | Shipping Status |
| 25MG | 65.00 | In Stock | Estimated to ship on 20 September 2026 | |
| 50MG | 95.00 | In Stock | Estimated to ship on 20 September 2026 | |
| 100MG | 135.00 | In Stock | Estimated to ship on 20 September 2026 | |
 | ||||
| Chemical Properites | |
|---|---|
Mol. Formula : C21H19ClN4O4 . CH3SO2H | Mol. Weight : 522.96 |
Appearance : Solid | Melting Point : Not available |
| For Laboratory research use only, not for drug, household or other uses. | |
Applications : Lenvatinib mesylate is a vascular endothelial growth factor receptor (VEGF) inhibitor which has activity against VEGF subtypes 1, 2, and 3 . It is used for the treatment of differentiated thyroid cancer that is either locally recurrent, metastatic, or progressive and did not respond to radioactive iodine treatment.
References : Flick C. A. et al.: J. Med. Chem., 60(15), 6480-6515, 2017.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!
Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!
Recently Viewed Products |
|---|
Related Products |
|---|